Zhuhai Sailong Pharmaceutical Co Ltd (002898) - Total Liabilities

Latest as of September 2025: CN¥337.07 Million CNY ≈ $49.32 Million USD

Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has total liabilities worth CN¥337.07 Million CNY (≈ $49.32 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002898 cash flow conversion to assess how effectively this company generates cash.

Zhuhai Sailong Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Zhuhai Sailong Pharmaceutical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Innowireless Co. Ltd
KQ:073490
Korea ₩52.47 Billion
Liberty Global PLC Class B
NASDAQ:LBTYB
USA $12.43 Billion
Union Insurance Co Ltd
TW:2816
Taiwan NT$12.06 Billion
Europap Tezol Kagit Sanayi Ve Ticaret AS
IS:TEZOL
Turkey TL1.22 Billion
Orbitech Co. Ltd
KQ:046120
Korea ₩56.53 Billion
Clearwater Paper Corporation
NYSE:CLW
USA $763.00 Million
Rockfields Property Indonesia Pt
JK:ROCK
Indonesia Rp114.17 Billion
Azkoyen
MC:AZK
Spain €71.89 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Zhuhai Sailong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Zhuhai Sailong Pharmaceutical Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.82 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhuhai Sailong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual total liabilities of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥308.95 Million
≈ $45.21 Million
+11.15%
2023-12-31 CN¥277.96 Million
≈ $40.67 Million
-13.58%
2022-12-31 CN¥321.64 Million
≈ $47.07 Million
+0.79%
2021-12-31 CN¥319.12 Million
≈ $46.70 Million
+40.61%
2020-12-31 CN¥226.96 Million
≈ $33.21 Million
+28.26%
2019-12-31 CN¥176.95 Million
≈ $25.89 Million
+91.71%
2018-12-31 CN¥92.30 Million
≈ $13.51 Million
-4.35%
2017-12-31 CN¥96.50 Million
≈ $14.12 Million
+88.43%
2016-12-31 CN¥51.21 Million
≈ $7.49 Million
-0.63%
2015-12-31 CN¥51.53 Million
≈ $7.54 Million
+5.32%
2014-12-31 CN¥48.93 Million
≈ $7.16 Million
-34.27%
2013-12-31 CN¥74.44 Million
≈ $10.89 Million
--

About Zhuhai Sailong Pharmaceutical Co Ltd

SHE:002898 China Biotechnology
Market Cap
$213.76 Million
CN¥1.46 Billion CNY
Market Cap Rank
#16282 Global
#4650 in China
Share Price
CN¥8.30
Change (1 day)
-5.03%
52-Week Range
CN¥6.57 - CN¥16.81
All Time High
CN¥29.47
About

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pan… Read more